Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions - ENDEAVOR II: Results Through 4 Years


The goal of the trial was to evaluate treatment with the Endeavor-eluting stent compared with a bare-metal stent (BMS) among patients undergoing percutaneous coronary intervention (PCI) for single de novo lesions.